ImmunoID NeXT: A Comprehensive Platform for Immuno- Oncology – Improving Neoantigen Prediction, Evaluating Tumor Dynamics, and Immunogenomics Profiling

Time: 2:30 pm
day: Day One

Details:

  • Accurate assessment of mutational landscape and putative neoantigens from the analytically-validated exome and transcriptome ImmunoID NeXT platform
  • Improved neoantigen presentation and binding predictions through a machine learning algorithm, SHERPA, built upon high quality immunopeptidomics training data from mono-allelic, and multi-allelic samples
  • Comprehensive immunogenomics profiling from a single sample to guide neoantigen-based therapies and biomarker discovery

Speakers:

Christelle Johnson